Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso
Arzouma Paul Yooda,1–3 Salam Sawadogo,3 Serge Théophile Soubeiga,1,2 Dorcas Obiri-Yeboah,4 Koumpingnin Nebie,3 Abdoul Karim Ouattara,1,2 Birama Diarra,1,2 Abibou Simpore,3 Yetema Dieudonné Yonli,3 Abdoul-Guaniyi Sawadogo,3 Bia Emile Drabo,3 Seimbou Zalla,3 Anita Pierr...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/residual-risk-of-hiv-hcv-and-hbv-transmission-by-blood-transfusion-bet-peer-reviewed-article-JBM |
id |
doaj-debf225a64e74fcd940352c9f6a63060 |
---|---|
record_format |
Article |
spelling |
doaj-debf225a64e74fcd940352c9f6a630602020-11-25T02:46:55ZengDove Medical PressJournal of Blood Medicine1179-27362019-02-01Volume 10535843871Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina FasoYooda APSawadogo SSoubeiga STObiri-Yeboah DNebie KOuattara AKDiarra BSimpore AYonli YDSawadogo AGDrabo BEZalla SSiritié APNana RSDahourou HSimpore JArzouma Paul Yooda,1–3 Salam Sawadogo,3 Serge Théophile Soubeiga,1,2 Dorcas Obiri-Yeboah,4 Koumpingnin Nebie,3 Abdoul Karim Ouattara,1,2 Birama Diarra,1,2 Abibou Simpore,3 Yetema Dieudonné Yonli,3 Abdoul-Guaniyi Sawadogo,3 Bia Emile Drabo,3 Seimbou Zalla,3 Anita Pierrette Siritié,3 Rodrigue Sosthène Nana,3 Honorine Dahourou,3 Jacques Simpore1,2 1Laboratory of Molecular Biology and Genetics (LaBioGene), Training and Research Unit in Life and Earth Sciences, University Ouaga I Professor Joseph Ki-Zerbo, Ouagadougou, Burkina Faso; 2Pietro Annigoni Biomolecular Research Center (CERBA), Ouagadougou, Burkina Faso; 3National Blood Transfusion Center (NBTC), Ouagadougou, Burkina Faso; 4Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Ghana Introduction: In sub-Saharan Africa, the high endemicity of blood-borne infections is a serious threat to transfusion safety. In order to improve transfusion safety, Burkina Faso has undertaken in recent years a reorganization of its blood-transfusion system through the creation of a National Blood Transfusion Center, which is the only blood operator in the whole country. This study aimed to estimate the residual risk of transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) by blood transfusion at the Regional Blood Transfusion Center (RBTC) of Ouagadougou.Methods: This was a retrospective study conducted at the RBTC of Ouagadougou between 2015 and 2017. Prevalence of infectious markers was calculated for first-time donors and incidence rates calculated for repeat donors who had made at least two donations of blood over the study period. Residual risks were estimated for the three viruses (HIV, HBV, and HCV) by multiplying the incidence rate per 100,000 person-years by the respective durations of serological windows.Results: Between 2015 and 2017, of a total of 84,299 blood donors, 68,391 (81.13%) were first-time donors compared to 15,908 (18.87%) repeat donors. The seroprevalence of HBV (8.56%) was twice that of HCV (4.40%) and fourfold that of HIV (1.80%). Incidence rates were 1,215, 2,601, and 1,599 per 100,000 donations for HIV, HCV, and HBV, respectively. In contrast, the estimated residual risk for HCV (1 in 213 donations) was double that of HBV (1 in 408 donations) and four times that of HIV (1 in 1,366).Conclusion: The residual risk of transmission of these viruses by blood transfusion remains high in repeat donors. An effective donor-retention and education policy could help to reduce this residual risk. Keywords: infectious diseases, prevalence, incidence, residual transfusion riskhttps://www.dovepress.com/residual-risk-of-hiv-hcv-and-hbv-transmission-by-blood-transfusion-bet-peer-reviewed-article-JBMInfectious diseasesPrevalenceIncidenceResidual transfusion risk |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yooda AP Sawadogo S Soubeiga ST Obiri-Yeboah D Nebie K Ouattara AK Diarra B Simpore A Yonli YD Sawadogo AG Drabo BE Zalla S Siritié AP Nana RS Dahourou H Simpore J |
spellingShingle |
Yooda AP Sawadogo S Soubeiga ST Obiri-Yeboah D Nebie K Ouattara AK Diarra B Simpore A Yonli YD Sawadogo AG Drabo BE Zalla S Siritié AP Nana RS Dahourou H Simpore J Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso Journal of Blood Medicine Infectious diseases Prevalence Incidence Residual transfusion risk |
author_facet |
Yooda AP Sawadogo S Soubeiga ST Obiri-Yeboah D Nebie K Ouattara AK Diarra B Simpore A Yonli YD Sawadogo AG Drabo BE Zalla S Siritié AP Nana RS Dahourou H Simpore J |
author_sort |
Yooda AP |
title |
Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso |
title_short |
Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso |
title_full |
Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso |
title_fullStr |
Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso |
title_full_unstemmed |
Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso |
title_sort |
residual risk of hiv, hcv, and hbv transmission by blood transfusion between 2015 and 2017 at the regional blood transfusion center of ouagadougou, burkina faso |
publisher |
Dove Medical Press |
series |
Journal of Blood Medicine |
issn |
1179-2736 |
publishDate |
2019-02-01 |
description |
Arzouma Paul Yooda,1–3 Salam Sawadogo,3 Serge Théophile Soubeiga,1,2 Dorcas Obiri-Yeboah,4 Koumpingnin Nebie,3 Abdoul Karim Ouattara,1,2 Birama Diarra,1,2 Abibou Simpore,3 Yetema Dieudonné Yonli,3 Abdoul-Guaniyi Sawadogo,3 Bia Emile Drabo,3 Seimbou Zalla,3 Anita Pierrette Siritié,3 Rodrigue Sosthène Nana,3 Honorine Dahourou,3 Jacques Simpore1,2 1Laboratory of Molecular Biology and Genetics (LaBioGene), Training and Research Unit in Life and Earth Sciences, University Ouaga I Professor Joseph Ki-Zerbo, Ouagadougou, Burkina Faso; 2Pietro Annigoni Biomolecular Research Center (CERBA), Ouagadougou, Burkina Faso; 3National Blood Transfusion Center (NBTC), Ouagadougou, Burkina Faso; 4Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Ghana Introduction: In sub-Saharan Africa, the high endemicity of blood-borne infections is a serious threat to transfusion safety. In order to improve transfusion safety, Burkina Faso has undertaken in recent years a reorganization of its blood-transfusion system through the creation of a National Blood Transfusion Center, which is the only blood operator in the whole country. This study aimed to estimate the residual risk of transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) by blood transfusion at the Regional Blood Transfusion Center (RBTC) of Ouagadougou.Methods: This was a retrospective study conducted at the RBTC of Ouagadougou between 2015 and 2017. Prevalence of infectious markers was calculated for first-time donors and incidence rates calculated for repeat donors who had made at least two donations of blood over the study period. Residual risks were estimated for the three viruses (HIV, HBV, and HCV) by multiplying the incidence rate per 100,000 person-years by the respective durations of serological windows.Results: Between 2015 and 2017, of a total of 84,299 blood donors, 68,391 (81.13%) were first-time donors compared to 15,908 (18.87%) repeat donors. The seroprevalence of HBV (8.56%) was twice that of HCV (4.40%) and fourfold that of HIV (1.80%). Incidence rates were 1,215, 2,601, and 1,599 per 100,000 donations for HIV, HCV, and HBV, respectively. In contrast, the estimated residual risk for HCV (1 in 213 donations) was double that of HBV (1 in 408 donations) and four times that of HIV (1 in 1,366).Conclusion: The residual risk of transmission of these viruses by blood transfusion remains high in repeat donors. An effective donor-retention and education policy could help to reduce this residual risk. Keywords: infectious diseases, prevalence, incidence, residual transfusion risk |
topic |
Infectious diseases Prevalence Incidence Residual transfusion risk |
url |
https://www.dovepress.com/residual-risk-of-hiv-hcv-and-hbv-transmission-by-blood-transfusion-bet-peer-reviewed-article-JBM |
work_keys_str_mv |
AT yoodaap residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT sawadogos residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT soubeigast residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT obiriyeboahd residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT nebiek residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT ouattaraak residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT diarrab residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT simporea residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT yonliyd residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT sawadogoag residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT drabobe residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT zallas residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT siritieap residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT nanars residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT dahourouh residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso AT simporej residualriskofhivhcvandhbvtransmissionbybloodtransfusionbetween2015and2017attheregionalbloodtransfusioncenterofouagadougouburkinafaso |
_version_ |
1724755817971843072 |